We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMCI icon
976
Treace Medical Concepts
TMCI
$259M
$533K ﹤0.01%
90,688
-1,812
-2% -$11.8K
TTEC icon
977
TTEC Holdings
TTEC
$103M
$529K ﹤0.01%
110,046
-52,417
-32% -$240K
TNL icon
978
Travel + Leisure Co
TNL
$4.54B
$526K ﹤0.01%
10,200
– –
CVGW
979
DELISTED
Calavo Growers
CVGW
$524K ﹤0.01%
+19,714
New +$515K
LOCO icon
980
El Pollo Loco
LOCO
$485M
$519K ﹤0.01%
+47,101
New +$467K
BRKR icon
981
Bruker
BRKR
$9.2B
$515K ﹤0.01%
12,500
– –
GENVR
982
Gen Digital Inc Contingent Value Rights
GENVR
$503K ﹤0.01%
+62,777
New +$441K
MBC icon
983
MasterBrand
MBC
$1.09B
$503K ﹤0.01%
46,000
– –
TDC icon
984
Teradata
TDC
$2.68B
$503K ﹤0.01%
+22,529
New +$490K
GILD icon
985
Gilead Sciences
GILD
$161B
$496K ﹤0.01%
4,475
-225
-5% -$23.9K
BVN icon
986
Compañía de Minas Buenaventura
BVN
$7.85B
$493K ﹤0.01%
30,000
– –
ANGI icon
987
Angi Inc
ANGI
$224M
$481K ﹤0.01%
+31,503
New +$455K
WSC icon
988
WillScot Mobile Mini Holdings
WSC
$4.8B
$478K ﹤0.01%
17,450
-3,000
-15% -$79.9K
BDC icon
989
Belden
BDC
$4B
$475K ﹤0.01%
4,100
+200
+5% +$21K
ILMN icon
990
Illumina
ILMN
$29.4B
$474K ﹤0.01%
4,964
– –
AMG icon
991
Affiliated Managers Group
AMG
$9.46B
$469K ﹤0.01%
2,383
-286
-11% -$49.6K
NEOG icon
992
Neogen
NEOG
$2.05B
$468K ﹤0.01%
98,000
+34,500
+54% +$198K
GENI icon
993
Genius Sports
GENI
$1.73B
$468K ﹤0.01%
45,000
– –
AVNT icon
994
Avient
AVNT
$3.45B
$457K ﹤0.01%
+14,129
New +$489K
TSQ icon
995
Townsquare Media
TSQ
$113M
$455K ﹤0.01%
57,500
+2,700
+5% +$19.1K
FIBK icon
996
First Interstate BancSystem
FIBK
$3.7B
$452K ﹤0.01%
+15,698
New +$423K
SPTN
997
DELISTED
SpartanNash
SPTN
$449K ﹤0.01%
+16,950
New +$339K
LWACU
998
LightWave Acquisition Corp Units
LWACU
$449K ﹤0.01%
+44,600
New +$448K
ACLS icon
999
Axcelis
ACLS
$4.12B
$448K ﹤0.01%
6,422
– –
HFWA icon
1000
Heritage Financial
HFWA
$1.24B
$446K ﹤0.01%
+18,729
New +$431K
38 39
40
41 42

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.